Antibody, and conjugate and preparation method and purpose thereof

The application of the invention relates to a new Trop-2 targeted humanized antibody, and an antibody-medicine conjugate, salt or stereoisomer, a salt solvate or stereoisomer solvate prepared from thenew Trop-2 targeted humanized antibody. Besides, the invention further relates to a medical composit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WANG JINGYI, WANG LICHUN, YU HAIMIN, XUE TONGTONG, XIAO LIANG, LIU DENGNIAN, YANG ZHOUNING, CAO XU
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The application of the invention relates to a new Trop-2 targeted humanized antibody, and an antibody-medicine conjugate, salt or stereoisomer, a salt solvate or stereoisomer solvate prepared from thenew Trop-2 targeted humanized antibody. Besides, the invention further relates to a medical composition and a medical preparation prepared from the antibody-medicine conjugate, the salt or the stereoisomer, the salt solvate or the stereoisomer solvate. In addition, the invention relates to the antibody-medicine conjugate or the pharmaceutically-acceptable salt or stereoisomer or solvate thereof.The medical composition or the medical preparation disclosed by the application can be used for preparing a composition for restraining cancer cell growth, proliferation or migration and preventing ortreating cancer. 本申请涉及新的靶向Trop-2的人源化抗体,以及由其制备的抗体-药物偶联物,盐或立体异构体,盐或立体异构体的溶剂合物。同时,本申请还涉及由抗体-药物偶联物,盐或立体异构体,盐或立体异构体的溶剂合物制备的药物组合物,药物制剂。此外,本申请的抗体-药物偶联物或者其药学上可接受的盐或立体异构体或者溶剂合物,本申请的药物组合物或药物制剂可用于制备用于抑制癌细胞生长、增殖或迁移,预防或治疗癌症的组合物。